Literature DB >> 20805427

Time in recurrent ventricular fibrillation and survival after out-of-hospital cardiac arrest.

Jocelyn Berdowski1, Monique ten Haaf, Jan G P Tijssen, Fred W Chapman, Rudolph W Koster.   

Abstract

BACKGROUND: Current resuscitation guidelines (2005 guidelines [G2005]) accelerate ventricular fibrillation (VF) recurrence. We investigated whether patients resuscitated under G2005 spend more time in VF and have better survival rates than patients treated under the 2000 guidelines (G2000). METHODS AND
RESULTS: We analyzed continuous ECG recordings of out-of-hospital cardiac arrests prospectively collected from January 2006 to January 2008. Patients treated according to G2000 (n=282) or G2005 (n=240) with VF as initial rhythm were included. We measured the total time a patient was in recurrent VF (the sum of all intervals from each onset of recurrent VF to each next successful shock) and the time a patient was in initial VF (time interval from rescuer arrival to first effective shock). The primary outcome measure was neurologically intact survival to discharge. The median time in recurrent VF was 2.7 minutes (quartile 1 to 3, 0.4 to 9.0 minutes) under G2000 versus 4.0 minutes (quartile 1 to 3, 0.2 to 11.6 minutes) under G2005 (P=0.03). Median time in initial VF was 2.7 minutes (quartile 1 to 3, 1.7 to 4.3 minutes) versus 3.9 minutes (quartile 1 to 3, 2.3 to 6.5 minutes), respectively (P<0.001). Increased time in recurrent VF was significantly associated with decreased neurologically intact survival in both G2000 use (odds ratio, 0.92; 95% confidence interval, 0.87 to 0.97; P=0.001) and G2005 use (odds ratio, 0.94; 95% confidence interval, 0.90 to 0.99; P=0.02). Neurologically intact survival decreased significantly with increasing time in initial VF under G2000 (odds ratio, 0.86; 95% confidence interval, 0.74 to 0.99; P=0.04). This observation was nonexistent in patients treated under G2005. Neurologically intact survival was 29% (82 of 282) under G2000 versus 27% (65 of 240) under G2005 (P=0.61).
CONCLUSIONS: With G2005, the time in recurrent VF remains associated with worse outcome. Studies of immediate defibrillation for recurrent VF are warranted.

Entities:  

Mesh:

Year:  2010        PMID: 20805427     DOI: 10.1161/CIRCULATIONAHA.110.958173

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Singapore Defibrillation Guidelines 2016.

Authors:  Chun Yue Francis Lee; Venkataraman Anantharaman; Swee Han Lim; Yih Yng Ng; Tek Siong Chee; Chong Meng Seet; Marcus Eng Hock Ong
Journal:  Singapore Med J       Date:  2017-07       Impact factor: 1.858

2.  Effects of intra-resuscitation antiarrhythmic administration on rearrest occurrence and intra-resuscitation ECG characteristics in the ROC ALPS trial.

Authors:  David D Salcido; Robert H Schmicker; Noah Kime; Jason E Buick; Sheldon Cheskes; Brian Grunau; Stephanie Zellner; Dana Zive; Tom P Aufderheide; Allison C Koller; Heather Herren; Jack Nuttall; Matthew L Sundermann; James J Menegazzi
Journal:  Resuscitation       Date:  2018-05-24       Impact factor: 5.262

3.  Incidence and outcomes of rearrest following out-of-hospital cardiac arrest.

Authors:  David D Salcido; Matthew L Sundermann; Allison C Koller; James J Menegazzi
Journal:  Resuscitation       Date:  2014-10-23       Impact factor: 5.262

4.  A Clinical Perspective on Sudden Cardiac Death.

Authors:  Demosthenes G Katritsis; Bernard J Gersh; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

5.  Compression-to-ventilation ratio and incidence of rearrest-A secondary analysis of the ROC CCC trial.

Authors:  David D Salcido; Robert H Schmicker; Jason E Buick; Sheldon Cheskes; Brian Grunau; Peter Kudenchuk; Brian Leroux; Stephanie Zellner; Dana Zive; Tom P Aufderheide; Allison C Koller; Heather Herren; Jack Nuttall; Matthew L Sundermann; James J Menegazzi
Journal:  Resuscitation       Date:  2017-04-06       Impact factor: 5.262

6.  Effect of Amiodarone and Hypothermia on Arrhythmia Substrates During Resuscitation.

Authors:  Joseph S Piktel; Yi Suen; Shalen Kouk; Danielle Maleski; Gary Pawlowski; Kenneth R Laurita; Lance D Wilson
Journal:  J Am Heart Assoc       Date:  2021-05-03       Impact factor: 5.501

Review 7.  Refractory Out of Hospital Cardiac Arrest.

Authors:  Madhan Shanmugasundaram; Kapildeo Lotun
Journal:  Curr Cardiol Rev       Date:  2018

8.  Comparison of Resuscitation Outcomes Between 2- or 3-Stacked Defibrillation Strategies With Minimally Interrupted Chest Compression and the Single Defibrillation Strategy: A Swine Cardiac Arrest Model.

Authors:  Soyeong Kim; Woo Jin Jung; Young Il Roh; Tae Youn Kim; Sung Oh Hwang; Kyoung-Chul Cha
Journal:  J Am Heart Assoc       Date:  2021-09-17       Impact factor: 5.501

Review 9.  Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD-What We Still Don't Know.

Authors:  Andreea Maria Ursaru; Antoniu Octavian Petris; Irina Iuliana Costache; Ana Nicolae; Adrian Crisan; Nicolae Dan Tesloianu
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-16

10.  2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 4. Adult advanced life support.

Authors:  Jaehoon Oh; Kyoung-Chul Cha; Jong-Hwan Lee; Seungmin Park; Dong-Hyeok Kim; Byung Kook Lee; Jung Soo Park; Woo Jin Jung; Dong Keon Lee; Young Il Roh; Tae Youn Kim; Sung Phil Chung; Young-Min Kim; June Dong Park; Han-Suk Kim; Mi Jin Lee; Sang-Hoon Na; Gyu Chong Cho; Ai-Rhan Ellen Kim; Sung Oh Hwang
Journal:  Clin Exp Emerg Med       Date:  2021-05-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.